XML 59 R49.htm IDEA: XBRL DOCUMENT
v3.22.2.2

License Agreement (Details Narrative) - Licensing Agreements [Member] | 9 Months Ended
--- | ---
Sep. 30, 2022 USD ($)
CTx-1301 [Member] |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
Accrued milestone payment | $ 250,000
Phase 3 Clinical Trial [Member] |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
Milestone payment | 250,000
New Drug Application [Member] |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
Milestone payment | 250,000
CTx-1301 and CTx-1302 [Member] |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
Milestone payment | 250,000
CTx-2103 [Member] |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
Milestone payment | 500,000
CTx-2103 [Member] |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
Milestone payment | $ 250,000

X
- Definition Accrued milestone payment. + References No definition available. + Details
Name: | CING_AccruedMilestonePayment
Namespace Prefix: | CING_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The value of milestone payment. + References No definition available. + Details
Name: | CING_MilestonePayment
Namespace Prefix: | CING_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_VestingAxis=CING_CTxOneThreeZeroOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=CING_PhaseThreeClinicalTrialMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=CING_NewDrugApplicationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=CING_CTxOneThreeZeroOneAndCTxOneThreeZeroTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=CING_CTxTwoThreeZeroThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=CING_CTxTwoThreeZeroOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |